Monosomy 7 and 7q- associated with myeloid malignancy

Blood Reviews

Volumn 11, Issue 1, 1997, Pages 46-55

  Johnson, E ^a   Cotter, F E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ANEMIA; ARTICLE; CHROMOSOME 7Q; CHROMOSOME ANALYSIS; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; LEUKEMOGENESIS; MONOSOMY 7; MYELODYSPLASIA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0030912565     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(97)90006-0     Document Type: Article

References (127)

1. Rowley J, Golomb H, Vardiman J. Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood 1981, 58: 759-767.
2. Yunis JJ. Chromosomal defects are found in most patients with acute non-lymphocytic leukemia. Cancer Genet Cytogene 1984; 11: 125-137.
3. Fagan K, Gill A, Henry R, Wilkinson I, Carey B. A summary of 7q interstitial deletions and exclusion mapping of the gene for beta-glucuronidase. J Medical Genet 1989; 26: 619-625.
4. Fourth International Workshop on Chromosomes in Leukemia: Correlation of morphology and karyotype. Cancer Genet Cytogenet 1984; 11: 249-360.
5. Johansson B, Mertens F, Mitelman F. Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumour suppressor loci. Genes Chromosomes Cancer 1993; 8: 205-218.
6. Freireich EJ, Whang J, Tjio JH, Levin RH, Brittin GM, Frei E. Refractory anemia, granulocytic hyperplasia of bone marrow and a missing chromosome in marrow cells. A new clinical syndrome? Clin Res 1964; 12: 284.
7. Van Wering E, Kamps W, Vossen J, Van Der List-Nuver C, Theunissen P. Myelodysplastic syndromes in childhood: three case reports. Br J Haematol 1985; 60: 137-142.
8. Hogge D, Shannon K, Kalousek D et al. Juvenile monosomy 7 syndrome: evidence that the disease originates in a pluripotent hemopoietic stem cell. Leukem Res 1987; 11: 705-709.
9. Michiels J, Mallios-Zorbala H, Prins M, Hahlen K. Simple monosomy 7 and myelodysplastic syndrome in thirteen patients without previous cytostatic treatment. Br J Haematol 1986; 64: 425-433.
10. Sieff C, Chessells J, Harvey A, Pickthall V, Lawler S. Monosomy 7 in childhood: a myeloproliferative disorder. Br J Haematol 1981; 49: 235-249.
11. Creutzig U, Cantu-Rajnoldi A, Ritter J et al. Myelodysplastic syndromes in childhood. Am J Pediatr Hematol Oncol 1987; 9: 324-330.
12. Brandwein J, Horsman D, Eaves A et al. Childhood myelodysplasia: suggested classification as myelodysplastic syndromes based on laboratory and clinical findings. Am J Pediatr Hematol Oncol 1990; 12: 63-70.
13. Hasle H, Jacobsen B, Pedersen N. Myelodysplastic syndromes in childhood: a population based study of nine cases. Br J Haematol 1992; 81: 495-498.
14. Tuncer M, Pagliuca A, Hicsonmez G, Yetgin S, Ozsoylu S, Mufti G. Primary myelodysplastic syndrome in children: the clinical experience in 33 cases. Br J Haematol 1992; 82: 347-353.
15. Passmore SJ, Hann IM, Stiller CA et al. Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system. Blood 1995; 85: 1742-1750.
16. Weiss K, Stass S, Williams D et al. Childhood monosomy 7 syndrome: clinical and in vitro studies. Leukemia 1987; 1:97-104.
17. Guinan E, Tarbell N, Tantravahi R, Weinstein H. Bone marrow transplantation for children with myelosdsplastic syndromes. Br J Haematol 1989; 73: 619-622.
18. Baranger L, Baruchel A, Leverger G, Schaison G, Berger R. Monosomy-7 in childhood hemopoietic disorders. Leukemia 1990; 4: 345-349.
19. Daghistani D, Toledano S, Curless R. Monosomy 7 syndrome. Clinical heterogeneity in children and adolescents. Cancer Genet Cytogenet 1990; 44: 263-269.
20. Mitelman F, Nilsson PG, Brandt L, Alimena G, Gastaldi R, Dallapiccola B. Chromosome pattern, occupation and clinical features in patients with acute non-lymphocytic leukemia. Cancer Genet Cytogenet 1981; 4: 197-214.
21. Rowley JD. Chromosome changes in acute leukaemia. Br J Haematol 1980; 44: 339-346.
22. Le Beau M, Albain K, Larson R et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no 5 and 7. J Clin Oncol 1986; 4: 325-345.
23. Yunis JJ, Rydell RE, Oken MM, Arnesen MA, Mayer MG, Lobell M. Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood 1986; 67: 1721-1730.
24. Paietta E, Gucalp R, Wiernik P. Monosomy 7 in multilineage and acute lymphoblastic leukaemia. Br J Haematol 1991; 79: 152-155.
25. Abrahamson G, Boultwood J, Madden J et al. Clonality of cell populations in refractory anaemia using combined approach, of gene loss and X-linked restriction fragment length polymorphism-methylation analyses. Br J Haematol 1991; 79: 550-555.
26. Le Beau MM, Espinosa III R, Neuman WL et al. Cytogenetic and molecular delineation of the smallest commonly deleted segment of chromosome 5 in malignant myeloid diseases. PNAS 1993; 90: 5484-5488.
27. Gibbons B, Lillington D, Monard S et al. Fluorescence in situ hybridisation studies to characterise complete and partial monosomy 7 in myeloid disorders. Genes, Chromosomes Cancer 1994; 10: 244-249.
28. Seizinger BR, Klinger HP, Junien C et al. Report of the committee on chromosome and gene loss in human neoplasia. Cytogenet Cell Genet 1991; 58: 1080-1096.
29. Knudson AG. Hereditary cancer, oncogenes and antioncogenes. Cancer Res 1985; 45: 1437-1443.
30. Luna-Fineman S S K, Lange BJ. Childhood monosomy 7: epidemiology, biology, and mechanistic implications. Blood 1995; 85: 1985-1999.
31. Jacobs RH, Cornbleet MA, Vardiman JW, Larson RA, Le Beau MM, Rowley JD. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 1986; 67: 1765-1772.
32. Kere J, Ruutu T, Davies K et al. Chromosome 7 long arm deletion in myeloid disorders: a narrow breakpoint region in 7q22 defined by molecular mapping. Blood 1989; 73: 230-234.
33. Kere J, Donis-Keller H, Ruutu X De la Chapelle A. Chromosome 7 long arm deletions in myeloid disorders: terminal DNA sequences are commonly conserved and breakpoints vary. Cytogenet Cell Genet 1989; 50: 226-229.
34. Scheres JMJC, Hustinx TWJ, Holdrinet RSG, Geraedts JPM, Hagemeijer A, van der Blij-Philipsen M. Translocation 1:7 in dyshaematopoiesis: possibly induced with a nonrandom geographic distribution. Cancer Genet Cytogenet 1984; 12: 283-294.
35. Scheres J, Hustinx T, Geraedts J, Leeksma C, Meltzer P. Translocation 1;7 in hematologic disorders: a brief review of 22 cases. Cancer Genet Cytogenet 1985; 18: 207-213.
36. Stefanescu D, Colita D, Nicoara S, Calin G. t(1;7)(p36;q32): a new recurring abnormality in primary myelodysplastic syndrome. Cancer Genet Cytogenet 1994; 75: 103-105.
37. Pedersen B. Survival of patients with t(1;7)(p11;p11). Cancer Genet and Cytogenet 1992; 60: 53-59.
38. Smadja N, Krulik M, de Gramont A, Audebert AA, Debray J. Translocation 1;7 in preleukemic states. Cancer Genet Cytogenet 1985; 18: 189-192.
39. Velloso ERP, Michaux L, Ferrant A et al. Deletions of the long arm of chromosome 7 in myeloid disorders: loss of band 7q32 implies worst prognosis. Br J Haematol 1996; 92: 574-581.
40. Yunis J, Lobell M, Arnesen M et al. Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. Br J Haematol 1988; 68: 189-194.
41. Parlier V, Van Melle G, et al. Beris P Hematologic, clinical and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Cancer Genet Cytogenet 1994; 78: 219-231.
42. Kojima S, Mimaya J, Tonouchi T, Yokochi T, Kajitani S. Erythropoiesis during an erythroblastic phase of chronic myeloproliferative disorder associated with monosomy 7. Br J Haematol 1987; 65: 391-394.
43. Rowley JD. Chromosome abnormalities in acute lymphoblastic leukemia. Cancer Genet Cytogenet 1980; 1: 263-271.
44. Neuman W, Rubin C, Rios R et al. Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders. Blood 1992; 79: 1501-1510.
45. Chan L, Sheer D, Drysdale H, Bevan D, Greaves M. Monosomy 7 and multipotential stem cell transformation. Br J Haematol 1985; 61: 531-539.
46. Russo C, Carroll A, Kohler S et al. Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a pediatric oncology group study. Blood 1991; 77: 1050-1056.
47. van Lom K, Hagemeijer A, Smit EME, Hahlen K, Groeneveld K, Lowenberg B. Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage. Leukemia 1995; 9: 1818-1821.
48. Wegelius R. Bone marrow dysfunctions preceding acute leukemia in children: a clinical study. Leukemia Research 1992; 16: 71-76.
49. Blank J, Lange B. Preleukemia in children. J Pediatr 1981; 98:565-568.
50. Nowell P, Wilmoth D, Lange B. Cytogenetics of childhood preleukemia. Cancer Genet Cytogenet 1983; 261-266.
51. Mertens F, Johansson B, Mitelman F. Age- and gender-related heterogeneity of cancer chromosome abnormalities. Cancer Genet Cytogenet 1993; 70: 6-11.
52. Bennett J, Catovsky D, Daniel M et al. Group TF-A-BFc-o: proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
53. Castro-Malaspina H, Shaison G, Passe S et al. Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Cancer 1984; 54: 675.
54. Evans J, Czepulkowski B, Gibbons B, Swansbury G, Chessells J. Childhood monosomy 7 revisited. Br J Haematol 1988; 69: 41-45.
55. Cuneo A, Fagioli F, Pazzi I et al. Morphologic, immunologic and cytogenetic studies in acute myeloid leukemia following occupational exposure to pesticides and organic solvents. Leuk Res 1992; 16: 789.
56. Golomb HM, Alimena G, Rowley JD, Vardiman JW, Testa JR, Sovik C. Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood 1982; 60: 40-411.
57. Narod S, Dube I. Occupational history and involvement of chromosomes 5 and 7 in acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1989; 38: 261-269.
58. Pedersen-Bjergaard J, Philip P, Larsen S, Jensen G, Byrsting K. Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood 1990; 76: 1083-1091.
59. Whang-Peng J, Young R, Lee E, Longo D, Schechter G, DeVita Jr V. Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. Blood 1988; 71: 403-414.
60. Pui C, Hancock M, Raimondi S et al. Myeloid neoplasia in children treated for solid tumours. Lancet 1990; 336: 417-421.
61. Rubin C, Arthur D, Woods W et al. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy. Blood 1991; 78: 2982-2988.
62. De Planque MM, Kluin-Nelemans HC, van Krieken HJM et al. Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults. Br J Haematol 1988; 70: 55-62.
63. Imashuku S, Hibi S, Kataoka-Morimoto et al. Myelodysplasia and acute myeloid leukaemia in cases of aplastic anaemia and congenital neutropenia following G-CSF administration. Br J Haematol 1995; 89: 188-190.
64. Kojima S, Tsuchida M, Matsuyama T. Myelodysplasia and leukemia after treatment of aplastic anemia with G-CSF. NEJM 1992; 326: 1294.
65. Haber DA, Housman DE. Rate-limiting steps: the genetics of pediatric cancers. Cell 1991; 64: 5-8.
66. Kostmann R. Infantile genetic agranulocytosis. Acta Paediatr Scand 1975; 64: 362-368.
67. Bonilla MA, Gillio AP, Ruggeiro M et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 1989; 320: 1574-1580.
68. Dale DC, Bonilla MA, Davis MW et al. A randomized controlled phase 111 trial of recombinant human granulocyte colony-stimulating factor (Filgrastim) for treatment of severe chronic neutropenia. Blood 1993; 81: 2496-2502.
69. Dong F, Brynes R, Tidow N, Welte K, Lowenberg B, Touw I. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. NEJM 1995; 333: 487-493.
70. Weinblatt ME, Scimeca P, James-Herry A, Sahdev I, Kochen J. Transformation of congenital neutropenia into monosomy 7 and acute nonlymphoblastic leukemia in a child treated with granulocyte colony-stimulating factor. J Pediatr 1995; 126: 263-265.
71. Zeidler C, Reiter A, Schofer O, Urban C, Riehm H, Weite K. Is severe congenital neutropenia (SCN) a pre-leukemia condition? Med Pediatr Oncol 1992; 20: 445 (abstr).
72. Wong W Williams D, Slovak ML. Terminal acute myelogenous leukemia in a patient with congenital agranulocytosis. Am J Hematol 1993; 43: 133-138.
73. Shwachman H, Diamond L, Oski F, Khaw K. The syndrome of pancreatic insufficiency and bone marrow dysfunction. J Pediatr 1964; 65: 645-663.
74. Woods W, Roloff J, Lukens J, Krivit W The occurrence of leukemia in patients with the Shwachman syndrome. J Pediatr 1981; 99: 425-428.
75. Seizinger BR. NF1: a prevalent cause of tumorigenesis in human cancers? Nature Genet 1993; 3: 97-99.
76. Bader JL, Miller RW. Neurofibromatosis and childhood leukemia. J Pediatr 1978; 92: 925-929.
77. Stiller CA, Chessells JM, Fitchett M. Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study. Br J Cancer 1994; 76: 969-972.
78. Shannon KM, Watterson J, Johnson P et al. Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: epidemiology and molecular analysis. Blood 1992; 79: 1311-1318.
79. Shannon KM, O'Connell P, Martin GA et al. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. NEJM 1994; 330: 597-601.
80. Kaneko Y, Maseki N, Sakurai M. Chromosome pattern in juvenile chronic myeloid leukaemia, myelodysplastic syndrome and acute leukaemia associated with neurofibromatosis. Leukemia 1989; 3: 36-41.
81. Riccardi VM, Eichner JE. Neurofibromatosis. Johns Hopkins: Baltimore, MD, 1986.
82. Stephenson J, Lizhen H, Mufti GJ. Possible co-existence of Ras activation and monosomy 7 in the leukaemic transformation of myelodysplastic syndromes. Leukemia Res 1995; 19: 741-748.
83. Neubauer A, Shannon KM, Liu E. Mutations of the ras protooncogenes in childhood monosomy 7. Blood 1991; 77: 594-598.
84. Bollag G, Clapp DW, Shih S et al. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nature Genet 1996; 12: 144-148.
85. Fanconi G. Familial constitutional panmyelocytopathy, Fanconi's anemia (FA). I. Clinical aspects. Semin Hematol 1967; 4: 233-240.
86. Auerbach A, Allen R. Leukemia and preleukemia in Fanconi anemia patients. Cancer Genet Cytogenet 1991; 51: 1-12.
87. Berger R, Le Coniat M, Schaison G. Chromosome abnormalities in bone marrow of Fanconi anemia patients. Cancer Genet Cytogenet 1993; 65: 47-50.
88. Stivrins T, Davis R, Sanger W, Fritz J, Purtilo D. Transformation of Fanconi's anemia to acute nonlymphocytic leukemia associated with emergence of monosomy 7. Blood 1984; 64: 173-176.
89. Hecht F, Hecht B, Morgan R, Sandberg A, Link M. Chromosome clues to acute leukemia in Down's syndrome. Cancer Genet Cytogenet 1986; 21: 93.
90. Bunin N, Nowell P, Belasco J et al. Chromosome 7 abnormalities in children with Down syndrome and preleukemia. Cancer Genet Cytogenet 1991; 54: 119-126.
91. Zipursky A, Thorner P, De Harven E, Christensen H, Doyle I Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome. Leukemia Res 1994; 18: 163-171.
92. Kaneko Y, Rowley JD, Variakojis D, Chilcote RR, Moohr JW, Patel D. Chromosome abnormalities in Down's syndrome patients with acute leukemia. Blood 1981; 58: 459-466.
93. Carroll WL, Rodman Morgan MS, Glader BE. Childhood bone marrow monosomy 7: a familial disorder? J Pediatr 1985; 107: 578-580.
94. Gilchrist D, Friedman J, Rogers P, Creighton S. Myelodysplasia and leukemia syndrome with monosomy 7: a genetic perspective. Am J Med Genet 1990; 35: 437-441.
95. Kamiyama R, Shibata T, Mori W. Two autopsy cases of atypical myeloproliferative disorder with group C monosomy occurring in siblings. Acta Pathol Jpn 1973; 23: 815.
96. Larsen WE, Schimke RW. Familial acute myelogenous leukemia with associated C-monosomy in two affected members. Cancer 1976; 38: 841.
97. Li FP, Hecht F, Kaiser-McCaw B, Baranko PV, Potter NU. Ataxia-pacytopenia syndrome of cerebellar ataxia, hypoplastic anemia, monosomy 7, and acute myelogenous leukemia. Cancer Genet Cytogenet 1981; 4: 189.
98. Paul B, Reid MM, Davison EV, Abela M, Hamilton PJ. Familial myelodysplasia: progressive disease associated with emergence of monosomy 7. Br J of Haematol 1987; 65: 321-323.
99. Chitambar CR, Robinson WA, Glode LM. Familial leukemia and aplastic anemia associated with monosomy 7. Am J Med 1983; 75: 756-762.
100. Shannon KM, Turhan AG, Chang SSY et al. Familial bone marrow monosomy 7. J Clin Invest 1989; 84: 984-989.
101. Shannon KM, Turhan AG, Rogers PCJ, Kan YW. Evidence implicating heterozygous deletion of chromosome 7 in the pathogenesis of familial leukaemia associated with monosomy 7. Genomics 1992; 14; 121-125.
102. Katz F, Webb D, Gibbons B et al. Possible evidence for genomic imprinting in childhood acute myeloblastic leukaemia associated with monosomy for chromosome 7. Br J Haematol 1992; 80: 332-336.
103. Savage P, Frenck R, Paderanga D, Emporer J, Shannon K. Parental origins of chromosome 7 loss in childhood monosomy 7. Leukemia 1994; 8: 485.
104. Appelbaum FR, Storb R, Ramberg RE et al. Allogeneic marrow transplantation in the treatment of preleukemia. Ann Intern Med 1984; 100: 689-693.
105. Borgstrom G, Teerenhovi L, Vuopio P et al. Clinical implications of monosomy 7 in acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1980; 2: 115-126.
106. Sanders J, Buckner C, Thomas E et al. Allogeneic marrow transplantation for children with juvenile chronic myclogenous leukemia. Blood 1988; 71: 1144-1146.
107. Appelbaum F, Storb R, Ramberg R et al. Treatment of preleukemic syndromes with marrow transplantation. Blood 1987; 69: 92-96.
108. Fischer K, McAllister Brown J, Scherer SW et al. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias. Blood 1996; 88 (suppl 1): 65a.
109. Kere J. Chromosome 7 long arm deletion breakpoints in preleukemia: mapping by pulsed field gel electrophoresis. Nucleic Acids Res 1989; 17: 1511-1520.
110. Kere J, Ruutu T, Lahtinen R, de la Chapelle A. Molecular characterisation of chromosome 7 long arm deletions in myeloid disorders. Blood 1987; 70: 1349-1353.
111. Lewis S, Abrahamson G, Boultwood J, Fidler C, Potter A, Wainscoat JS. Molecular characterization of the 7q deletion in myeloid disorders. Br J Haematol 1996; 96: 75-80.
112. Butcher M, Frenck R, Emperor J, Paderanga D, Maybee D, Shannon K. Molecular evidence that childhood monosomy 7 syndrome is distinct from juvenile chronic myelogenous leukemia and other childhood myeloproliferative disorders. Genes, Chromosomes Cancer 1995; 12: 50.
113. Abrahamson G, Rack K, Oscier D, Fitchett M, Buckle V, Wainscoat J. Comparison of cytogenetic and restriction fragment length polymorphism analses for the detection of loss of chromosomal material in clonal hemopoietic disorders. Am J Hematol 1993; 42: 171-176.
114. Zhao L, Van Oort J, Cork A, Liang J. Comparison between interphase and metaphase cytogenetics in detecting chromosome 7 defects in hematological neoplasias. Am J Hematol 1993; 43: 205-211.
115. Kibbelaar R, Mulder J, Dreef E et al. Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: a comparison of banding and fluorescence in situ hybridization. Blood 1993; 82: 904-913.
116. Bentz M, Dohner H, Cabot G, Lichter P. Fluorescence in situ hybridization in leukemias: 'The FISH are spawning!'. Leukemia 1994; 8: 1447-1452.
117. Kolluri RV, Manuelidis L, Cremer T, Sait S, Gezer S, Raza A. Detection of monosomy 7 in interphase cells of patients with myeloid disorders. Am J Haematol 1990; 33: 117-122.
118. Johnson EJ, Scherer SW, Osborne L et al. Molecular definition of a narrow interval at 7q22.1 associated with myelodysplasia. Blood 1996; 87: 3579-3586.
119. Stephenson J, Czepulkowski B, Hirst W, Mufti GJ. Deletion of the acetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML). Leukemia Res 1996; 20: 235-241.
120. Law ML, Cai G-Y, Lin F-K et al. Chromosomal assignment of the human erythropoietin gene and its DNA polymorphism. PNAS 1986; 83: 6920.
121. Kumar S, White D, Takai S, Turczynowicz S, Juttner C, Hughes T. Apoptosis regulatory gene NEDD2 maps to human chromosome segment 7q34-35, a region frequently affected in haematological neoplasms. Hum Genet 1995; 95: 641-644.
122. Kibbelaar R, Mulder J, Van Kamp H et al. Nonradioactive in situ hybridisation of the translocation t(1;7) in myeloid malignancies. Genes, Chromosomes Cancer 1992; 4: 128-134.
123. Gerritsen W, Donohue J, Bauman J et al. Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid but not in the lymphoid lineage as detected by fluorescent in situ hybridization. Blood 1992; 80: 217-224.
124. Baurmann H, Cherif D, Berger R. Interphase cytogenetics by fluorescent in situ hybridization (FISH) for characterization of monosomy-7 associated mycloid disorders. Leukemia 1993; 7: 384-391.
125. Johansson B, Arheden K, Hoglund M et al. Fluorescence in situ hybridization analysis of whole-arm 7;12 translocations in hematologic malignancies. Genes, Chromosomes Cancer 1995; 14: 56-62.
126. Le Beau MM. One FISH, two FISH, red FISH, blue FISH. Nat Genet 1996; 12: 341-344.
127. Fisher E, Scambler P. Human haploinsufficiency - one for sorrow, two for joy. Nat Genet 1994; 7: 5-7.